Evidence map›Paper›PMID 21083584›Full record

ArticleAlimentary pharmacology & therapeutics2011

Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States.

F Burton, S Alkaade, D Collins, V Muddana, A Slivka, R E Brand, A Gelrud, P A Banks, S Sherman, M A Anderson and 13 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2024
    Article
  4. Observational
  5. Article
  6. Review
  7. Frontiers in pharmacology · 2022
    Article
  8. Article
  9. Medical Management of Pain in Chronic Pancreatitis.Digestive diseases and sciences · 2017
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Design and implementation of INSPPIRE.Journal of pediatric gastroenterology and nutrition · 2014
    Article
  15. Article
  16. Pharmacological pain management in chronic pancreatitis.World journal of gastroenterology · 2013
    Review
  17. Innovation and hard work: The 2015 George E. Palade Medal Award Lecture.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
    Article
  18. Mechanism, assessment and management of pain in chronic pancreatitis: Recommendations of a multidisciplinary study group.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 1 country.

F BurtonSt. Louis University, MO, USA.
S Alkaade
D Collins
V Muddana
A Slivka
R E Brand
A Gelrud
P A Banks
S Sherman
M A Anderson
J Romagnuolo
C Lawrence
J Baillie
T B Gardner
M D Lewis
S T Amann
J G Lieb
M O'Connell
E D Kennard
D Yadav
D C Whitcomb
C E Forsmark
North American Pancreatic Study Group
University of Pittsburgh · USMedical University of South Carolina · USSaint Louis University · USUniversity of Florida · USBrigham and Women's Hospital · USDartmouth–Hitchcock Medical Center · USDuke Medical Center · USMayo Clinic in Florida · USNorth Mississippi Medical Center · USUniversity Medical Center · USUniversity of Michigan–Ann Arbor · USUniversity of Pennsylvania · US

Funding

North American Pancreatitis Study 2 (NAPS2)R01DK061451 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHITCOMB, DAVID CLEMENT · 2002 to 2010
$4.9M
NAPS2 Continuation Genome Wide Association Study of PancreatitisR56DK061451 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHITCOMB, DAVID CLEMENT · 2011 to 2011
$1.3M
NIDDK NIH HHS DK61451NIDDK NIH HHS R01 DK061451NIDDK NIH HHS R56 DK061451
6 · The paper itself

Abstract

backgroundEffectiveness of medical therapies in chronic pancreatitis has been described in small studies of selected patients.

aimTo describe frequency and perceived effectiveness of non-analgesic medical therapies in chronic pancreatitis patients evaluated at US referral centres.

methodsUsing data on 516 chronic pancreatitis patients enrolled prospectively in the NAPS2 Study, we evaluated how often medical therapies [pancreatic enzyme replacement therapy (PERT), vitamins/antioxidants (AO), octreotide, coeliac plexus block (CPB)] were utilized and considered useful by physicians.

resultsOral PERT was commonly used (70%), more frequently in the presence of exocrine insufficiency (EI) (88% vs. 61%, P < 0.001) and pain (74% vs. 59%, P < 0.002). On multivariable analyses, predictors of PERT usage were EI (OR 5.14, 95% CI 2.87-9.18), constant (OR 3.42, 95% CI 1.93-6.04) or intermittent pain (OR 1.98, 95% CI 1.14-3.45). Efficacy of PERT was predicted only by EI (OR 2.16, 95% CI 1.36-3.42). AO were tried less often (14%) and were more effective in idiopathic and obstructive vs. alcoholic chronic pancreatitis (25% vs. 4%, P = 0.03). Other therapies were infrequently used (CPB - 5%, octreotide - 7%) with efficacy generally <50%.

conclusionsPancreatic enzyme replacement therapy is commonly utilized, but is considered useful in only subsets of chronic pancreatitis patients. Other medical therapies are used infrequently and have limited efficacy.

Indexed as

Abdominal PainAdolescentAdultAgedAged, 80 and overAntioxidantsAutonomic Nerve BlockEnzyme Replacement TherapyFemaleGastrointestinal AgentsHumansMaleMiddle AgedOctreotidePancreasPancreatitis, ChronicAntioxidantsGastrointestinal AgentsOctreotideVitamins

Identifiers

PMID21083584
PMCPMC3142582
OpenAlexW2109037470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.